Chul-Woong Woo1, Jae Im Kwon1, Sang Tae Kim1, Kyung won Kim2, YoonSeok Choi3, Jinil Kim1, Jeong Kon Kim2, Su Jeong Ham1, Seul I Lee1, Ho-jin Kim1, Jeeheon Kang1, and Dong-Cheol Woo1
1Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea, Republic of, 2Department of Radiology, Asan Medical Center, 3Medical research institute, Gangneung Asan Hospital
Synopsis
Recent evidence
indicated that hydrogen sulfide is capable of attenuating ischemia/reperfusion
(I/R) injury in brain. However, the influence of H2S administration timing on its
neuroprotective efficacy has not yet been assessed, thus we aimed to
perform this study which used MRI and 1H-MRS in rats with focal
cerebral I/R injury. Our study demonstrated that hydrogen sulfide
administration at 1 minute before reperfusion showed better neuroprotective effect than that at 30
minutes before
reperfusion.
PURPOSE
Emerging evidences have
suggested that hydrogen sulfide (H2S) may alleviate the cellular
damage associated with cerebral ischemia/reperfusion (I/R) injury by inhibiting
oxidative stress, inflammation, and apoptosis.1,2 We hypothesized
that the time of H2S delivery has influence upon its neuroprotective
efficacy. We aim to prove our hypothesis with the use of magnetic resonance
imaging (MRI) and 1H magnetic resonance spectroscopy (1H-MRS). METHODS
Animal
model: Transient middle cerebral artery occlusion
model with temporary intraluminal thread insertion for 60 minutes was used for
I/R injury. As a H2S donor, sodium hydrosulfide (NaHS) dissolved in
saline were used. Thirty-two male Sprague-Dawley rats were randomly divided
into four groups: NaHS-30 and NaHS-1 (NaHS
administration 30 and 1 minutes before reperfusion, respectively), sham (no I/R injury), and control (I/R injury) groups. Rats were sacrificed 24 hours after
ischemia and histologic analysis was performed including apoptosis rate analysis
using Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL).3
MRI
and 1H-MRS: MRI and 1H-MRS were obtained at baseline (i.e. before
ischemia) and 3, 9, and 24 hours after ischemia. MRI included T2 map,
T2-weighted images (T2-WI) and apparent diffusion coefficient (ADC) map. 1H-MRS was performed to analyze concentrations of N-acetyl-L-aspartate
(cNAA) and NAA + glutamate + taurine (cNGT).4
Image analysis: The total infarct volume at 24 hours after
ischemia was measured at T2-WI using 2D volumetry technique. The degree of
midline shift due to cerebral edema (MLS) was quantified at 24 hours after
ischemia on T2-WI. The degree of ischemic injury in the ipsilateral (ischemic
core and peri-infarct region) and contralateral regions was evaluated by measuring mean ADC values on ADC map, T2 values on T2 map, and cNAA and cNGT on 1H-MRS.5 The relative
values of ADC (rADC) and T2 (rT2) were calculated as ratios, i.e., ipsilateral value
/ contralateral value.
Statistical
analysis: The total infarct volume, MLS, rADC, rT2, cNAA,
cNGT, and apoptosis rate in the four groups were compared by one-way ANOVA with
multiple comparison post-hoc test.RESULTS
Total infarct volume and midline shift: Both total infarct volume and MLS at 24
hours post-ischemia were lowest in the NaHS-1 group, followed by NaHS-30 group
and control group, respectively (Fig 1), indicative of neuroprotective effect
of NaHS (p<0.05, ANOVA).
Degree of
ischemic injury: The ischemic/infarcted area showed low rADC, high rT2, low cNAA, and cNGT
levels on ADC map, T2 map, and 1H-MRS. On serial ADC maps, the rADC of ischemic core decreased over time
and reached at similar level 24 hours post ischemia in control, NaHS-1, NaHS-30
groups (Fig 2). In contrast, the serial change of rADC of peri-infarct region
differed significantly between groups; the highest value was observed in NaHS-1
group, followed by NaHS-30 group, and control group, also suggesting better
neuroprotective effects in NaHS-1 group compared to NaHS-30 group. The rT2
value also showed similar tendency with rADC in that rT2 of peri-infarct region
differed significantly between NaHS-1 group and NaHS-30 group (Fig 3). However,
on serial 1H-MRS of both ischemic core and peri-infarct region (Fig
4), the cNAA and cNGT did not differ significantly between NaHS-1 group and
NaHS-30 group.
Degree
of apoptosis: In both the ischemic core and peri-infarct
regions, apoptosis rate was significantly lower in NaHS treatment groups
compared with control group and also significantly lower in NaHS-1 group than
in NaHS-30 group (Fig 5).DISCUSSION
The
present study demonstrated that H2S treatment 1 minute before reperfusion showed better neuroprotective
effect than H2S treatment 30 minutes before reperfusion based on volumetry, ADC map,
and histologic examination. ADC map was the most sensitive sequence to evaluate
the therapeutic effects of NaHS.CONCLUSION
The timing of H2S
treatment has influenced on its neuroprotective effects. In order to
incorporate these results into the clinical application, further studies investigating
the precise time-dependent H2S efficacy against cerebral I/R injury
and the mechanism of neuroprotective effect are required.Acknowledgements
No acknowledgement found.References
1. Gheibi
S, Aboutaleb N, Khaksari M, et al. Hydrogen sulfide protects the brain against
ischemic reperfusion injury in a transient model of focal cerebral ischemia. J
Mol Neurosci. 2014;54(2):264-270.
2. Yin
J, Zeng QH, Shen Q, et al. Neuroprotective mechanism of hydrogen sulfide after
cerebral ischemia-reperfusion in rats. Zhonghua Yi Xue Za Zhi. 2013;93(11):868-872.
3. Zhao
H, Sapolsky RM, Steinberg GK. Interrupting reperfusion as a stroke therapy:
Ischemic postconditioning reduces infarct size after focal ischemia in rats. J
Cereb Blood Flow Metab. 2006;26(9):1114-1121.
4. Prichard
JW. The ischemic penumbra in stroke: Prospects for analysis by nuclear magnetic
resonance spectroscopy. Res Publ Assoc Res Nerv Ment Dis. 1993;71:153-174.
5. Barber
PA, Hoyte L, Kirk D, et al. Early t1- and t2-weighted mri signatures of
transient and permanent middle cerebral artery occlusion in a murine stroke
model studied at 9.4 t. Neurosci Lett. 2005;388(1):54-59.